MDCalc

Memorial Sloan-Kettering Cancer Center (MSKCC) Risk of Recurrence

Predicts the 5-year probability of treatment failure among patients with newly diagnosed renal cell carcinoma (RCC).

Histology

If the histology is unknown, select “None.”

Symptoms 

cm

Pathologic stage

Result:

Please fill out required fields.
Advice

Use results alongside a thorough clinical evaluation, clinician judgment, local guidelines, and specialist input to guide:

  • Prognosis counseling.
  • Follow-up intensity, including visit frequency, laboratory studies, and imaging.
  • Adjuvant therapy decisions, such as whether to use pembrolizumab.
  • Clinical trial enrollment.